A polymorphism in the promoter is associated with EZH2 expression but not with outcome in advanced pancreatic cancer patients

Pharmacogenomics , April 2014, Vol. 15, No. 5, Pages 609-618.
Source: Future Medicine: Pharmacogenomics - Category: Genetics & Stem Cells Tags: article Source Type: research